Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era
Authors:
Top Cited Papers
- 1 May 2026
- journal article
- Published by American Medical Association (AMA) in JAMA Surgery
- Vol. 161 (5) , 546
Abstract
This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.Keywords
This publication has 3 references indexed in Scilit:
- Great Debates: Undergoing the Knife versus Pill-Popping—The Comparative Efficacy and Cost-Effectiveness of Bariatric Surgery and GLP-1 Receptor Agonists in the Management of ObesityThe American Surgeon™, 2025
- Metabolic Bariatric Surgery in the Era of GLP-1 Receptor Agonists for Obesity ManagementJAMA Network Open, 2024
- Weight loss between glucagon‐like peptide‐1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta‐analysisObesity, 2022